Stock Scorecard



Stock Summary for Phibro Animal Health Corp - Class A (PAHC) - $22.06 as of 3/25/2025 3:04:54 PM EST

Total Score

14 out of 30

Safety Score

39 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for PAHC

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PAHC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PAHC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PAHC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PAHC (39 out of 100)

Stock Price Rating (Max of 10) 7
Historical Stock Price Rating (Max of 10) 6
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 4
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for PAHC

Should You Consider Retaining PBH Stock in Your Portfolio Now? 3/25/2025 12:11:00 PM
Looking for a Growth Stock? 3 Reasons Why Phibro ( PAHC ) is a Solid Choice 3/24/2025 4:45:00 PM
Insulet Gains 62.9% in a Year: What's Driving the Stock? 3/24/2025 12:09:00 PM
Should You Consider Retaining ZBH Stock in Your Portfolio Now? 3/21/2025 4:15:00 PM
Here's Why You Should Retain AMED Stock in Your Portfolio Now 3/19/2025 3:22:00 PM
Is it Apt to Retain HAE Stock in Your Portfolio for Now? 3/18/2025 2:37:00 PM
Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock? 3/17/2025 2:15:00 PM
PAHC vs. BSX: Which Stock Should Value Investors Buy Now? 3/14/2025 3:40:00 PM
Is Phibro Animal Health ( PAHC ) a Great Value Stock Right Now? 3/14/2025 1:40:00 PM
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? 3/13/2025 1:39:00 PM

Financial Details for PAHC

Company Overview

Ticker PAHC
Company Name Phibro Animal Health Corp - Class A
Country USA
Description Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2024
Next Earnings Date 5/6/2025

Stock Price History

Last Day Price 22.06
Price 4 Years Ago 18.48
Last Day Price Updated 3/25/2025 3:04:54 PM EST
Last Day Volume 178,892
Average Daily Volume 308,189
52-Week High 26.42
52-Week Low 11.89
Last Price to 52 Week Low 85.53%

Valuation Measures

Trailing PE 44.81
Industry PE 36.51
Sector PE 40.40
5-Year Average PE 16.57
Free Cash Flow Ratio 6.68
Industry Free Cash Flow Ratio 11.75
Sector Free Cash Flow Ratio 47.07
Current Ratio Most Recent Quarter 3.20
Total Cash Per Share 3.30
Book Value Per Share Most Recent Quarter 6.09
Price to Book Ratio 3.62
Industry Price to Book Ratio 8.88
Sector Price to Book Ratio 21.82
Price to Sales Ratio Twelve Trailing Months 0.81
Industry Price to Sales Ratio Twelve Trailing Months 86.87
Sector Price to Sales Ratio Twelve Trailing Months 27.97
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 20,337,600
Market Capitalization 448,647,456
Institutional Ownership N/A

Dividends

Ex-Dividend Date 3/5/2025
Previous Dividend Amount 0.1200
Current Dividend Amount 0.1200
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.48
Trailing Annual Dividend Yield 2.19%
Forward Annual Dividend Rate 0.48
Forward Annual Dividend Yield 2.19%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 2.30%
5-Year Average Dividend Yield 3.25%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 2.05%
Dividend Payout Ratio 100.00%

Income Statement

Quarterly Earnings Growth YOY 162.10%
Annual Earnings Growth -92.59%
Reported EPS 12 Trailing Months 0.48
Reported EPS Past Year 0.89
Reported EPS Prior Year 1.19
Net Income Twelve Trailing Months 19,317,000
Net Income Past Year 2,416,000
Net Income Prior Year 32,606,000
Quarterly Revenue Growth YOY 23.70%
5-Year Revenue Growth 3.72%
Operating Margin Twelve Trailing Months 11.60%

Balance Sheet

Total Cash Most Recent Quarter 67,074,000
Total Cash Past Year 114,613,000
Total Cash Prior Year 81,281,000
Net Cash Position Most Recent Quarter -572,056,000
Net Cash Position Past Year -197,471,000
Long Term Debt Past Year 312,084,000
Long Term Debt Prior Year 333,836,000
Total Debt Most Recent Quarter 639,130,000
Equity to Debt Ratio Past Year 0.45
Equity to Debt Ratio Most Recent Quarter 0.28
Total Stockholder Equity Past Year 256,641,000
Total Stockholder Equity Prior Year 282,509,000
Total Stockholder Equity Most Recent Quarter 246,802,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 15,327,000
Free Cash Flow Per Share Twelve Trailing Months 0.75
Free Cash Flow Past Year 46,356,000
Free Cash Flow Prior Year -38,484,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.35
MACD Signal -0.18
20-Day Bollinger Lower Band 19.63
20-Day Bollinger Middle Band 22.41
20-Day Bollinger Upper Band 25.20
Beta 0.58
RSI 47.71
50-Day SMA 19.97
150-Day SMA 15.64
200-Day SMA 16.80

System

Modified 3/26/2025 4:01:27 AM EST